Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer

BACKGROUND: The efficacy of adjuvant chemotherapy in patients with 8th edition stage IB (tumor size ≤4 cm) non-small cell lung cancer (NSCLC) remains unclear. METHODS: We identified 9757 eligible patients (non-chemotherapy group: n=8303; chemotherapy group: n=1454) between 2004 and 2016 from the Sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yangyang, Wan, Bing, Zhu, Suhua, Zhang, Tianli, Xie, Jingyuan, Liu, Hongbing, Zhan, Ping, Lv, Tangfeng, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828472/
https://www.ncbi.nlm.nih.gov/pubmed/35155190
http://dx.doi.org/10.3389/fonc.2021.784289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828472/
https://www.ncbi.nlm.nih.gov/pubmed/35155190
http://dx.doi.org/10.3389/fonc.2021.784289

Ejemplares similares